Stay updated on Tucidinostat & Tislelizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Tucidinostat & Tislelizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucidinostat & Tislelizumab in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page revision history now shows a new revision tag, v3.5.3, replacing the previous v3.5.2. This indicates a metadata/version update to the page rather than changes to the study information.
    Difference
    0.1%
    Check dated 2026-04-30T16:36:33.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The record history reflects an update to the study status and recruitment status, including a shift to **Completed** for the trial.
    Difference
    0.7%
    Check dated 2026-04-23T15:29:56.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A new revision entry v3.5.2 was added and the v3.5.0 entry was removed in the record history. This is an administrative update to the page's revision log.
    Difference
    0.1%
    Check dated 2026-04-16T11:50:36.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    48 days ago
    Change Detected
    Summary
    System revision history updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T20:23:36.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added to the record history, and the v3.4.2 entry was removed.
    Difference
    0.1%
    Check dated 2026-03-11T17:28:41.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the study record history. Removed the government funding notice and the older Revision: v3.4.1.
    Difference
    0.9%
    Check dated 2026-02-11T02:38:18.000Z thumbnail image

Stay in the know with updates to Tucidinostat & Tislelizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucidinostat & Tislelizumab in NSCLC Clinical Trial page.